Germline mutations and developmental mosaicism underlying EGFR -mutant lung cancer.
Risa BurrIgnaty LeshchinerChristina L CostantinoMartin BlohmerTilak SundaresanJustin ChaKarsen SeegerSara GuayBrian P DanyshIra GoreRaquel A JacobsKara SlowikFilippo UtroKahn RhrissorrakraiChaya LevovitzJaimie L BarthTaronish DubashBrian ChirnLaxmi ParidaLecia V SequistJochen K LennerzMari Mino-KenudsonShyamala MaheswaranKamila NaxerovaGad GetzDaniel A HaberPublished in: medRxiv : the preprint server for health sciences (2023)
While the development of multiple primary tumors in smokers with lung cancer can be attributed to carcinogen-induced field cancerization, the occurrence of multiple primary tumors in individuals with EGFR -mutant lung cancer who lack known environmental exposures remains unexplained. We identified ten patients with early-stage, resectable non-small cell lung cancer who presented with multiple anatomically distinct EGFR -mutant tumors. We analyzed the phylogenetic relationships among multiple tumors from each patient using whole exome sequencing (WES) and hypermutable poly-guanine (poly-G) repeat genotyping, as orthogonal methods for lineage tracing. In two patients, we identified germline EGFR variants, which confer moderately enhanced signaling when modeled in vitro . In four other patients, developmental mosaicism is supported by the poly-G lineage tracing and WES, indicating a common non-germline cell-of-origin. Thus, developmental mosaicism and germline variants define two distinct mechanisms of genetic predisposition to multiple EGFR -mutant primary tumors, with implications for understanding their etiology and clinical management.
Keyphrases
- small cell lung cancer
- epidermal growth factor receptor
- end stage renal disease
- tyrosine kinase
- early stage
- newly diagnosed
- ejection fraction
- dna repair
- chronic kidney disease
- single cell
- peritoneal dialysis
- prognostic factors
- wild type
- genome wide
- stem cells
- risk assessment
- air pollution
- dna methylation
- patient reported outcomes
- endothelial cells
- patient reported
- oxidative stress
- smoking cessation
- cell therapy
- rectal cancer
- life cycle